A privately held medical device company, tSoterix Medical, Inc. (SMI) was originally formed around development and deployment of innovative medical treatments addressing neuropsychiatric and neurological disorders and rehabilitation: a leader in non-invasive neuromodulation and integrated brain monitoring technologies. The firm is structured such as to provides researchers, clinicians, and patients with unique and adaptable solutions encompassing electrical, magnetic, and ultrasound stimulation and synergistic technologies.
